Decreased ITIH5 expression is associated with poor prognosis in primary gastric cancer.
about
Recent advances in the molecular diagnostics of gastric cancerGenome-wide in vivo RNAi screen identifies ITIH5 as a metastasis suppressor in pancreatic cancer.ITIH5 mediates epigenetic reprogramming of breast cancer cells.Gene expression analysis combined with functional genomics approach identifies ITIH5 as tumor suppressor gene in cervical carcinogenesis.ITIH5 induces a shift in TGF-β superfamily signaling involving Endoglin and reduces risk for breast cancer metastasis and tumor death.A Strategy for Discovery of Endocrine Interactions with Application to Whole-Body Metabolism.
P2860
Decreased ITIH5 expression is associated with poor prognosis in primary gastric cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Decreased ITIH5 expression is associated with poor prognosis in primary gastric cancer.
@en
Decreased ITIH5 expression is associated with poor prognosis in primary gastric cancer.
@nl
type
label
Decreased ITIH5 expression is associated with poor prognosis in primary gastric cancer.
@en
Decreased ITIH5 expression is associated with poor prognosis in primary gastric cancer.
@nl
prefLabel
Decreased ITIH5 expression is associated with poor prognosis in primary gastric cancer.
@en
Decreased ITIH5 expression is associated with poor prognosis in primary gastric cancer.
@nl
P2093
P2860
P1433
P1476
Decreased ITIH5 expression is associated with poor prognosis in primary gastric cancer.
@en
P2093
Bai-wei Zhao
Jian-chuan Xia
Jing-jing Zhao
Qiu-zhong Pan
Shan-shan Jiang
Xiao-fei Zhang
Xiao-feng Tang
P2860
P2888
P356
10.1007/S12032-014-0053-1
P577
2014-06-10T00:00:00Z